Midocalm in patients with multiple sclerosis

Zhurnal Nevropatolgii i Psikhiatrii im. S S Korsakova

Volumn 100, Issue 6, 2000, Pages 24-28

  Lasch, N Yu ^a   Avakyan, G N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL MUSCLE RELAXANT; TOLPERISONE;

ADULT; ARTICLE; CLINICAL TRIAL; DISABILITY; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; LOCOMOTION; MALE; MULTIPLE SCLEROSIS; PILOT STUDY; SKELETAL MUSCLE;

ADULT; DISABILITY EVALUATION; FEMALE; HUMANS; LOCOMOTION; MALE; MULTIPLE SCLEROSIS; MUSCLE RELAXANTS, CENTRAL; MUSCLE, SKELETAL; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TOLPERISONE;

EID: 0347116280     PISSN: 00444588     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bever C. T. The current status of studies of aminopyredines in patient with multiple sclerosis. Ann Neurol 1994; 36: 118-121.
2. Comi J., Martinelli V., Fillippi M. Interferon betatreatment in multiple sclerosis: the European clinical trials. Multipal Sclerosis 1996; 1: 317-320.
3. Fillippi M., Horsfield M.A. Quantitative brain MRI lesion load predicts the course of clinically isoletied syndroms suggestive of multiple sclerosis. Neurology 1994; 44: 635-641.
4. Kurtzke J.F. Clinical definition for multiple sclerosis treatment trials. Ann Neurol 1994; 36: 73-79.
5. Peyser J.M. et al. Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol 1990; 47: 94-97.
6. Poser C.M., Paty D. W., Scheinberg I. et al. New diagnostic criteria for multiple sclerosis guidelines for reach protocols. Ann Neurol 1983; 13: 227-231.
7. Sibley W.A. Therapeutic claims in multiple sclerosis. N Y Demos Publ 1992; 93-124.